Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Orchestra BioMed Holdings, Inc. (OBIO)
USD3.69
-0.01 (-0.14%)
US NASDAQ Healthcare Biotechnology
Address
150 Union Square Drive 18938
New Hope, PA, US
New Hope, PA, US
CEO
David Hochman
Website
orchestrabiomed.com
IPO
2020-08-04
CIK 1814114 ISIN US68572M1062
Description
Orchestra BioMed Holdings, Inc. operates as an innovative company in the biomedical sector. Its leading product candidates are BackBeat Cardiac Neuromodulation Therapy (CNT), designed to manage hypertension, and the Virtue Sirolimus AngioInfusion Balloon (SAB), aimed at treating atherosclerotic artery disease. The company's offerings also encompass FreeHold retractors, which are solutions for minimally invasive surgical procedures. Orchestra BioMed has formed key alliances to advance its products: a strategic collaboration with Medtronic focuses on developing and commercializing BackBeat CNT for pacemaker-indicated patients suffering from hypertension. Additionally, a partnership with Terumo Corporation is dedicated to the development and market introduction of Virtue SAB for artery disease. The company's headquarters are located in New Hope, Pennsylvania.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD3.69
-0.01 (-0.14%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
314.1K
Beta
0.50
Float Shares
40.29M
Free Float %
68.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.84% | -1.22% | -1.69% | +6.28% | -8.14% | -2.17% | +53.21% | -76.12% | -59.60% | -64.39% | -64.39% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (4 ratings, all time)
Buy
Price Targets & DCF
Current price
3.69
Low
12.00
+225.6%
Consensus
12.00
+225.6%
Median
12.00
+225.6%
High
12.00
+225.6%
Ratings Trend (MoM)
88% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 5 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 1 |
12.00
+225.6%
|
| All Time | 2 |
12.00
+225.6%
|
Quality scores
Altman Z-Score
-2.96
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+1,169.2% ★ Q1'26: -87.3% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+33.1% ★ Q1'26: +32.7% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-189.1% Q1'26: -20,320.0% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-154.7% Q1'26: +0.0% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+104,168.4% Q1'26: +163,941.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.03× Q1'26: -0.02× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 6 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 4 Rev. Ana. 3 EPS Ana. |
Dec 2029 3 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.53M
est: 4.31M (-17.9%)
|
2.76M
est: 2.22M (+24.5%)
|
2.64M
est: 3.21M (-17.8%)
|
33.48M
est: 3.47M (+865.4%)
|
1.68M
350.6K – 5.54M
-51.7% YoY
|
888.3K
482.4K – 1.95M
-47.0% YoY
|
14.88M
14.87M – 14.88M
+1,575.0% YoY
|
53.64M
29.13M – 117.72M
+260.5% YoY
|
111.31M
60.44M – 244.26M
+107.5% YoY
|
| EBITDA |
-32.44M
est: -2.58M (-1,155.7%)
|
-51.22M
est: -1.33M (-3,752.2%)
|
-63.99M
est: -1.93M (-3,223.1%)
|
-51.48M
est: -2.08M (-2,373.9%)
|
-1.01M
-3.32M – -210.4K
+51.7% YoY
|
-533.0K
-1.17M – -289.4K
+47.0% YoY
|
-8.93M
-8.93M – -8.92M
-1,575.0% YoY
|
-32.18M
-70.63M – -17.48M
-260.5% YoY
|
-66.78M
-146.56M – -36.27M
-107.5% YoY
|
| EBIT |
-32.66M
est: -2.58M (-1,164.3%)
|
-51.51M
est: -1.33M (-3,773.8%)
|
-64.30M
est: -1.93M (-3,239.1%)
|
-51.81M
est: -2.08M (-2,389.7%)
|
-1.01M
-3.32M – -210.4K
+51.7% YoY
|
-533.0K
-1.17M – -289.4K
+47.0% YoY
|
-8.93M
-8.93M – -8.92M
-1,575.0% YoY
|
-32.18M
-70.63M – -17.48M
-260.5% YoY
|
-66.78M
-146.56M – -36.27M
-107.5% YoY
|
| Net Income |
-33.61M
est: -510.34M (+93.4%)
|
-49.12M
est: -83.51B (+99.9%)
|
-61.02M
est: -63.64B (+99.9%)
|
-52.96M
est: -66.48B (+99.9%)
|
-68.79B
-75.86B – -61.73B
-3.5% YoY
|
-60.19B
-61.61B – -58.76B
+12.5% YoY
|
-37.28B
-50.67B – -23.89B
+38.1% YoY
|
-11.77B
-30.06B – -4.78B
+68.4% YoY
|
12.67B
5.14B – 32.34B
+207.6% YoY
|
| SGA |
13.92M
est: 10.43M (+33.5%)
|
20.26M
est: 4.88M (+314.9%)
|
23.93M
est: 7.07M (+238.4%)
|
26.91M
est: 7.64M (+252.2%)
|
3.69M
772.6K – 12.21M
-51.7% YoY
|
1.96M
1.06M – 4.30M
-47.0% YoY
|
32.79M
32.78M – 32.79M
+1,575.0% YoY
|
118.20M
64.19M – 259.40M
+260.5% YoY
|
245.27M
133.19M – 538.25M
+107.5% YoY
|
| EPS |
-1.32
est: -13.86 (+90.5%)
|
-1.48
est: -1.46 (-1.0%)
|
-1.66
est: -1.66 (-0.2%)
|
-1.11
est: -1.74 (+36.3%)
|
-1.77
-1.98 – -1.61
-1.4% YoY
|
-1.57
-1.60 – -1.53
+10.9% YoY
|
-1.02
-1.32 – -0.62
+35.4% YoY
|
-0.31
-0.78 – -0.12
+69.8% YoY
|
0.33
0.13 – 0.84
+207.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-45.40M
OE per share TTM
-0.59
Owner's Yield
-0.02%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
32.4%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
17
Total invested
12.88M
Insider transactions (90d)
1
Beneficial owners (>5%)
1
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1) BlackRock, Inc. | 1.94M | 5.10% | — | 1.93M | 1.94M | — | HC | Delaware | 2024-11-08 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
17
-49 vs prev Q
New positions
6
Closed positions
52
Increased
12
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | RTW INVESTMENTS, LP | 8.31M +— (+0.0%) | 34.47M +13.9M (+67.3%) | 21.63% +0.000 pp | 0.35% +0.092 pp | USD14.12 -70.6% | 12 qtrs — |
| 2 | PERCEPTIVE ADVISORS LLC | 5.13M -165.3K (-3.1%) | 21.28M +8.2M (+62.1%) | 13.35% -0.431 pp | 0.38% +0.000 pp | USD10.64 -61.0% | 12 qtrs — |
| 3 | VANGUARD GROUP INC | 1.60M +122.7K (+8.3%) | 6.66M +3.0M (+81.2%) | 4.18% +0.320 pp | 0.00% +0.000 pp | USD7.52 -44.8% | 12 qtrs — |
| 4 | ALYESKA INVESTMENT GROUP, L.P. | 1.00M -365.5K (-26.8%) | 4.15M +763.6K (+22.5%) | 2.60% -0.952 pp | 0.01% +0.002 pp | USD2.48 +67.3% | 2 qtrs — |
| 5 | BLACKROCK, INC. | 630.9K -33.4K (-5.0%) | 2.62M +970.7K (+58.9%) | 1.64% -0.087 pp | 0.00% +0.000 pp | USD5.12 -18.9% | 6 qtrs — |
| 6 | AFFINITY ASSET ADVISORS, LLC | 572.8K -154.5K (-21.2%) | 2.38M +573.5K (+31.8%) | 1.49% -0.402 pp | 0.14% -0.022 pp | USD2.48 +67.3% | 2 qtrs — |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 473.4K +86.6K (+22.4%) | 1.97M +1.0M (+104.8%) | 1.23% +0.226 pp | 0.00% +0.000 pp | USD7.66 -45.8% | 12 qtrs — |
| 8 | PRICE T ROWE ASSOCIATES INC /MD/ | 364.6K -57.0K (-13.5%) | 1.51M +468.0K (+44.7%) | 0.95% -0.148 pp | 0.00% +0.000 pp | USD9.98 -58.4% | 13 qtrs — |
| 9 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 263.8K +83.3K (+46.2%) | 1.09M +647.2K (+144.6%) | 0.69% +0.217 pp | 0.00% +0.000 pp | USD7.73 -46.3% | 12 qtrs — |
| 10 | KNOTT DAVID M JR | 250.0K +55.0K (+28.2%) | 1.04M +553.9K (+114.5%) | 0.65% +0.143 pp | 0.48% +0.285 pp | USD2.93 +41.6% | 3 qtrs — |
| 11 | MILLENNIUM MANAGEMENT LLC | 243.5K -130.5K (-34.9%) | 1.01M +82.9K (+8.9%) | 0.63% -0.340 pp | 0.00% +0.000 pp | USD2.68 +54.9% | 5 qtrs — |
| 12 | 683 CAPITAL MANAGEMENT, LLC | 204.1K +204.1K (+100.0%) | 846.9K +846.9K (+100.0%) | 0.53% +0.532 pp | 0.04% +0.037 pp | USD4.15 +0.0% | 1 qtrs NEW |
| 13 | JANE STREET GROUP, LLC | 173.8K +108.2K (+165.2%) | 721.1K +558.6K (+343.8%) | 0.45% +0.282 pp | 0.00% +0.000 pp | USD3.54 +17.2% | 3 qtrs — |
| 14 | MARSHALL WACE, LLP | 171.7K +171.7K (+100.0%) | 712.5K +712.5K (+100.0%) | 0.45% +0.447 pp | 0.00% +0.001 pp | USD4.15 +0.0% | 3 qtrs — |
| 15 | POINT72 ASSET MANAGEMENT, L.P. | 161.9K +161.9K (+100.0%) | 672.1K +672.1K (+100.0%) | 0.42% +0.422 pp | 0.00% +0.001 pp | USD4.15 +0.0% | 1 qtrs NEW |
| 16 | STATE STREET CORP | 159.0K +58.3K (+57.9%) | 660.0K +410.2K (+164.2%) | 0.41% +0.152 pp | 0.00% +0.000 pp | USD6.55 -36.6% | 12 qtrs — |
| 17 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 155.1K +57.0K (+58.1%) | 643.8K +400.5K (+164.6%) | 0.40% +0.149 pp | 0.00% +0.000 pp | USD3.48 +19.3% | 5 qtrs — |
| 18 | RENAISSANCE TECHNOLOGIES LLC | 151.3K -229.2K (-60.2%) | 627.9K -315.8K (-33.5%) | 0.39% -0.597 pp | 0.00% 0.000 pp | USD2.57 +61.5% | 3 qtrs — |
| 19 | GOLDMAN SACHS GROUP INC | 134.1K +110.4K (+467.4%) | 556.4K +497.8K (+849.5%) | 0.35% +0.288 pp | 0.00% +0.000 pp | USD4.08 +1.7% | 6 qtrs — |
| 20 | DAFNA CAPITAL MANAGEMENT LLC | 126.8K -236.8K (-65.1%) | 526.4K -375.4K (-41.6%) | 0.33% -0.617 pp | 0.12% -0.101 pp | USD2.48 +67.3% | 2 qtrs — |
| 21 | NORTHERN TRUST CORP | 110.9K +8.3K (+8.1%) | 460.2K +205.9K (+80.9%) | 0.29% +0.022 pp | 0.00% +0.000 pp | USD7.64 -45.7% | 12 qtrs — |
| 22 | QUBE RESEARCH & TECHNOLOGIES LTD | 106.7K +80.8K (+311.6%) | 443.0K +378.7K (+588.8%) | 0.28% +0.211 pp | 0.00% +0.000 pp | USD3.74 +11.0% | 2 qtrs — |
| 23 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 95.6K +95.6K (+100.0%) | 396.9K +396.9K (+100.0%) | 0.25% +0.249 pp | 0.00% +0.003 pp | USD4.15 +0.0% | 1 qtrs NEW |
| 24 | BARCLAYS PLC | 94.5K +62.7K (+197.4%) | 392.2K +228.9K (+140.1%) | 0.25% +0.163 pp | 0.00% +0.000 pp | USD3.62 +14.6% | 12 qtrs — |
| 25 | IFP ADVISORS, INC | 86.7K +— (+0.0%) | 359.8K +144.8K (+67.3%) | 0.23% +0.000 pp | 0.01% +0.003 pp | USD5.06 -18.0% | 12 qtrs — |
| 26 | TWO SIGMA INVESTMENTS, LP | 86.6K +86.6K (+100.0%) | 359.2K +359.2K (+100.0%) | 0.23% +0.225 pp | 0.00% +0.001 pp | USD4.15 +0.0% | 1 qtrs NEW |
| 27 | MORGAN STANLEY | 81.9K +71.5K (+692.9%) | 339.7K +314.1K (+1,226.8%) | 0.21% +0.186 pp | 0.00% +0.000 pp | USD4.44 -6.5% | 12 qtrs — |
| 28 | OMERS ADMINISTRATION CORP | 67.1K +67.1K (+100.0%) | 278.5K +278.5K (+100.0%) | 0.17% +0.175 pp | 0.00% +0.002 pp | USD4.15 +0.0% | 1 qtrs NEW |
| 29 | HOLOS INTEGRATED WEALTH LLC | 51.6K +— (+0.0%) | 222.4K +59.9K (+36.8%) | 0.13% +0.000 pp | 0.12% +0.029 pp | USD4.00 +3.8% | 5 qtrs — |
| 30 | XTX TOPCO LTD | 50.4K +15.5K (+44.6%) | 209.0K +122.6K (+142.0%) | 0.13% +0.041 pp | 0.01% +0.001 pp | USD3.06 +35.6% | 3 qtrs — |
| 31 | HUDSON BAY CAPITAL MANAGEMENT LP | 49.4K +49.4K (+100.0%) | 205.1K +205.1K (+100.0%) | 0.13% +0.129 pp | 0.00% +0.001 pp | USD4.15 +0.0% | 1 qtrs NEW |
| 32 | TD ASSET MANAGEMENT INC | 45.7K -47.0K (-50.7%) | 189.6K -40.2K (-17.5%) | 0.12% -0.122 pp | 0.00% +0.000 pp | USD14.14 -70.7% | 12 qtrs — |
| 33 | SQUAREPOINT OPS LLC | 44.3K +44.3K (+100.0%) | 184.0K +184.0K (+100.0%) | 0.12% +0.116 pp | 0.00% +0.000 pp | USD4.15 +0.0% | 3 qtrs — |
| 34 | NEWEDGE ADVISORS, LLC | 44.1K +— (+0.0%) | 182.9K +73.6K (+67.3%) | 0.11% +0.000 pp | 0.00% +0.000 pp | USD2.68 +54.9% | 3 qtrs — |
| 35 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 32.5K +— (+0.0%) | 134.6K +54.0K (+66.9%) | 0.08% +0.000 pp | 0.00% +0.000 pp | USD14.15 -70.7% | 12 qtrs — |
| 36 | CITADEL ADVISORS LLC | 30.2K -23.8K (-44.1%) | 125.2K -8.7K (-6.5%) | 0.08% -0.062 pp | 0.00% +0.000 pp | USD3.47 +19.6% | 6 qtrs — |
| 37 | — | 30.0K +30.0K (+100.0%) | 117.3K +117.3K (+100.0%) | 0.08% +0.078 pp | 0.05% +0.046 pp | USD4.15 +0.0% | 1 qtrs NEW |
| 38 | TWO SIGMA ADVISERS, LP | 27.1K +27.1K (+100.0%) | 112.5K +112.5K (+100.0%) | 0.07% +0.071 pp | 0.00% +0.000 pp | USD4.15 +0.0% | 1 qtrs NEW |
| 39 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 25.0K +— (+0.0%) | 103.8K +41.8K (+67.3%) | 0.07% +0.000 pp | 0.00% +0.001 pp | USD2.68 +54.9% | 3 qtrs — |
| 40 | LIGHTHOUSE INVESTMENT PARTNERS, LLC | 24.9K +24.9K (+100.0%) | 103.3K +103.3K (+100.0%) | 0.06% +0.065 pp | 0.00% +0.003 pp | USD4.15 +0.0% | 1 qtrs NEW |
| 41 | CRESSET ASSET MANAGEMENT, LLC | 20.0K -10.0K (-33.3%) | 83.0K +8.6K (+11.6%) | 0.05% -0.026 pp | 0.00% +0.000 pp | USD2.48 +67.3% | 2 qtrs — |
| 42 | CITIGROUP INC | 19.5K +19.4K (+47,358.5%) | 80.8K +80.6K (+79,067.6%) | 0.05% +0.051 pp | 0.00% +0.000 pp | USD4.15 +0.0% | 11 qtrs — |
| 43 | HIGHTOWER ADVISORS, LLC | 18.3K +— (+0.0%) | 75.8K +30.5K (+67.3%) | 0.05% +0.000 pp | 0.00% +0.000 pp | USD5.34 -22.3% | 10 qtrs — |
| 44 | BALYASNY ASSET MANAGEMENT L.P. | 18.3K +18.3K (+100.0%) | 75.8K +75.8K (+100.0%) | 0.05% +0.048 pp | 0.00% +0.000 pp | USD4.15 +0.0% | 1 qtrs NEW |
| 45 | BANK OF AMERICA CORP /DE/ | 17.5K -13.6K (-43.6%) | 72.8K -4.4K (-5.6%) | 0.05% -0.035 pp | 0.00% +0.000 pp | USD4.56 -9.0% | 11 qtrs — |
| 46 | BNP PARIBAS ARBITRAGE, SNC | 17.0K +16.4K (+2,915.4%) | 70.6K +69.2K (+4,945.0%) | 0.04% +0.043 pp | 0.00% +0.000 pp | USD4.13 +0.5% | 5 qtrs — |
| 47 | AQR CAPITAL MANAGEMENT LLC | 16.3K -822.0 (-4.8%) | 67.6K +25.2K (+59.3%) | 0.04% -0.002 pp | 0.00% +0.000 pp | USD2.48 +67.3% | 2 qtrs — |
| 48 | CREATIVE PLANNING | 16.3K -811.0 (-4.7%) | 67.6K +25.2K (+59.4%) | 0.04% -0.002 pp | 0.00% +0.000 pp | USD2.66 +56.0% | 3 qtrs — |
| 49 | VIRTU FINANCIAL LLC | 13.6K +13.6K (+100.0%) | 57.0K +57.0K (+100.0%) | 0.04% +0.036 pp | 0.00% +0.002 pp | USD4.15 +0.0% | 1 qtrs NEW |
| 50 | ABLE FINANCIAL GROUP, LLC | 13.4K +— (+0.0%) | 55.6K +22.4K (+67.3%) | 0.03% +0.000 pp | 0.01% +0.004 pp | USD5.14 -19.3% | 6 qtrs — |
| 51 | UBS GROUP AG | 11.4K +7.6K (+198.5%) | 47.3K +37.8K (+399.6%) | 0.03% +0.020 pp | 0.00% +0.000 pp | USD4.24 -2.1% | 11 qtrs — |
| 52 | GSA CAPITAL PARTNERS LLP | 10.8K +10.8K (+100.0%) | 45.0K +45.0K (+100.0%) | 0.03% +0.028 pp | 0.00% +0.004 pp | USD4.15 +0.0% | 1 qtrs NEW |
| 53 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 9.2K +9.2K (+100.0%) | 38.2K +38.2K (+100.0%) | 0.02% +0.024 pp | 0.00% +0.003 pp | USD4.15 +0.0% | 1 qtrs NEW |
| 54 | CANADA PENSION PLAN INVESTMENT BOARD | 7.1K +7.1K (+100.0%) | 29.5K +29.5K (+100.0%) | 0.02% +0.019 pp | 0.00% +0.000 pp | USD4.15 +0.0% | 1 qtrs NEW |
| 55 | JPMORGAN CHASE & CO | 4.6K +4.1K (+875.7%) | 19.0K +17.9K (+1,532.2%) | 0.01% +0.011 pp | 0.00% +0.000 pp | USD4.22 -1.7% | 11 qtrs — |
| 56 | MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 2.7K +2.7K (+100.0%) | 11.4K +11.4K (+100.0%) | 0.01% +0.007 pp | 0.00% +0.000 pp | USD4.15 +0.0% | 1 qtrs NEW |
| 57 | HARBOUR INVESTMENTS, INC. | 2.0K +— (+0.0%) | 8.3K +3.3K (+67.3%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD4.00 +3.8% | 10 qtrs — |
| 58 | GF FUND MANAGEMENT CO. LTD. | 1.1K +1.1K (+100.0%) | 4.6K +4.6K (+100.0%) | 0.00% +0.003 pp | 0.00% +0.000 pp | USD4.15 +0.0% | 1 qtrs NEW |
| 59 | TOWER RESEARCH CAPITAL LLC (TRC) | 646.00 +646.0 (+100.0%) | 2.7K +2.7K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD4.15 +0.0% | 12 qtrs — |
| 60 | OPTIVER HOLDING B.V. | 312.00 +— (+0.0%) | 1.3K +521.0 (+67.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.48 +67.3% | 2 qtrs — |
| 61 | ROYAL BANK OF CANADA | 371.00 -6.0K (-94.2%) | 1.0K -15.0K (-93.8%) | 0.00% -0.016 pp | 0.00% +0.000 pp | USD2.95 +40.7% | 11 qtrs — |
| 62 | SBI SECURITIES CO., LTD. | 6.00 +— (+0.0%) | 25.00 +10.0 (+66.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.67 +55.4% | 5 qtrs — |
| 63 | PATHSTONE HOLDINGS, LLC | — -1.0M (-100.0%) | — -2.5M (-100.0%) | 0.00% -2.620 pp | 0.00% -0.010 pp | USD— | 2 qtrs SOLD |
| 64 | QUADRATURE CAPITAL LTD | — -15.6K (-100.0%) | — -38.5K (-100.0%) | 0.00% -0.041 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 65 | KNOLL CAPITAL MANAGEMENT, LLC | — -455.1K (-100.0%) | — -421.2K (-100.0%) | 0.00% -1.186 pp | 0.00% -0.226 pp | USD— | 3 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 43 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Simplify Propel Opportunities ETF SURI | 1.13% | 875.4K | 2.82% |
| 2 | iShares Micro-Cap ETF IWC | 0.04% | 533.7K | 0.60% |
| 3 | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF GSSC | 0.02% | 260.9K | 0.20% |
| 4 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.02% | 76.0K | 0.40% |
| 5 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.02% | 12.3K | 0.19% |
| 6 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.01% | 159.4K | 0.35% |
| 7 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.01% | 10.7K | 0.35% |
| 8 | iShares Russell 2000 Growth ETF IWO | 0.01% | 1.50M | 0.24% |
| 9 | ProShares Ultra Nasdaq Biotechnology BIB | 0.01% | 8.0K | 1.19% |
| 10 | Xtrackers Russell 2000 UCITS ETF 1C XRSU.L | 0.01% | 171.9K | 0.30% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.50
Neutral
Ratio by volume
1.00
Neutral
Buys
1
Sells
2
Shares acquired
1.25M
Shares disposed
1.25M
Cash buys
—
Cash sales
1.00
Net activity
-32
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-27 | RTW INVESTMENTS, LP | 10% Owner | X-InTheMoney | A | Common Stock | 1,250,032 | 0.00 | 125.00 | 9,556,095 | I | ↗ |
| 2026-03-25 | Sherman Darren | Director / Officer | F-InKind | D | Common Stock, par value $0.0001 per share | 33,317 | 4.57 | 152.3K | 1,204,252 | D | ↗ |
| 2026-03-25 | Hochman David P | Director / Officer | F-InKind | D | Common Stock, par value $0.0001 per share ("Common Stock") | 32,438 | 4.57 | 148.2K | 1,054,029 | D | ↗ |
| 2026-03-25 | Aiello Joshua | Officer | F-InKind | D | Common Stock, par value $0.0001 per share ("Common Stock") | 241 | 4.57 | 1.1K | 18,644 | D | ↗ |
| 2026-03-13 | Hochman David P | Director / Officer | P-Purchase | A | Common Stock, par value $0.0001 per share ("Common Stock") | 10,000 | 4.29 | 42.9K | 1,086,467 | D | ↗ |
| 2026-02-12 | Taylor Andrew Lawrence | Officer | A-Award | A | Common Stock, par value $0.0001 per share | 181,000 | 0.00 | — | 632,493 | D | ↗ |
| 2026-02-12 | Sherman Darren | Director / Officer | A-Award | A | Common Stock, par value $0.0001 per share | 397,000 | 0.00 | — | 1,237,569 | D | ↗ |
| 2026-02-12 | Hochman David P | Director / Officer | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 504,000 | 0.00 | — | 1,076,467 | D | ↗ |
| 2026-02-12 | Aiello Joshua | Officer | A-Award | A | Stock Option (Right to Buy) | 70,000 | 3.82 | 267.4K | 70,000 | D | ↗ |
| 2026-02-05 | Cleary Chris | Director | F-InKind | D | Common Stock, par value $0.0001 per share ("Common Stock") | 676 | 3.71 | 2.5K | 36,901 | D | ↗ |
| 2026-01-28 | Sherman Darren | Director / Officer | A-Award | A | Stock Option | 34,974 | 2.85 | 99.7K | 34,974 | D | ↗ |
| 2026-01-02 | Taylor Andrew Lawrence | Officer | F-InKind | D | Common Stock, par value $0.0001 per share | 3,452 | 4.31 | 14.9K | 451,493 | D | ↗ |
| 2026-01-02 | Sherman Darren | Director / Officer | F-InKind | D | Common Stock, par value $0.0001 per share | 5,588 | 4.31 | 24.1K | 840,569 | D | ↗ |
| 2026-01-02 | Aiello Joshua | Officer | F-InKind | D | Common Stock, par value $0.0001 per share ("Common Stock") | 241 | 4.31 | 1.0K | 18,885 | D | ↗ |
| 2025-12-10 | Taylor Andrew Lawrence | Officer | F-InKind | D | Common Stock, par value $0.0001 per share | 8,670 | 4.67 | 40.5K | 454,945 | D | ↗ |
| 2025-12-10 | Hochman David P | Director / Officer | F-InKind | D | Common Stock, par value $0.0001 per share ("Common Stock") | 40,355 | 4.67 | 188.5K | 572,467 | D | ↗ |
| 2025-11-25 | Taylor Andrew Lawrence | Officer | F-InKind | D | Common Stock, par value $0.0001 per share | 3,071 | 5.35 | 16.4K | 463,615 | D | ↗ |
| 2025-11-25 | Sherman Darren | Director / Officer | F-InKind | D | Common Stock, par value $0.0001 per share | 40,340 | 5.35 | 215.8K | 846,157 | D | ↗ |
| 2025-11-14 | Hochman David P | Director / Officer | P-Purchase | A | Common Stock, par value $0.0001 per share ("Common Stock") | 5,000 | 4.07 | 20.4K | 612,822 | D | ↗ |
| 2025-11-13 | Hochman David P | Director / Officer | F-InKind | D | Common Stock, par value $0.0001 per share ("Common Stock") | 3,283 | 4.18 | 13.7K | 607,822 | D | ↗ |
| 2025-09-19 | Aryeh Jason | Director | P-Purchase | A | Common Stock, par value $0.0001 per share | 1,000 | 2.45 | 2.5K | 108,482 | D | ↗ |
| 2025-09-17 | Taylor Andrew Lawrence | Officer | F-InKind | D | Common Stock, par value $0.0001 per share | 16,102 | 2.46 | 39.6K | 466,686 | D | ↗ |
| 2025-09-17 | Hochman David P | Director / Officer | F-InKind | D | Common Stock | 3,283 | 2.46 | 8.1K | 446,048 | I | ↗ |
| 2025-09-17 | Aiello Joshua | Officer | F-InKind | D | Common Stock, par value $0.0001 per share ("Common Stock") | 203 | 2.46 | 499.38 | 19,126 | D | ↗ |
| 2025-09-03 | Sherman Darren | Director / Officer | F-InKind | D | Common Stock, par value $0.0001 per share | 40,340 | 2.72 | 109.7K | 886,497 | D | ↗ |
| 2025-08-25 | Taylor Andrew Lawrence | Officer | P-Purchase | A | Common Stock, par value $0.0001 per share | 2,000 | 2.55 | 5.1K | 482,788 | D | ↗ |
| 2025-08-25 | Sherman Darren | Director / Officer | P-Purchase | A | Common Stock, par value $0.0001 per share | 3,000 | 2.62 | 7.9K | 926,837 | D | ↗ |
| 2025-08-25 | Fain Eric S | Director | P-Purchase | A | Common Stock, par value $0.0001 per share | 5,760 | 2.61 | 15.0K | 71,709 | I | ↗ |
| 2025-08-21 | Hochman David P | Director / Officer | P-Purchase | A | Common Stock, par value $0.0001 per share ("Common Stock") | 6,000 | 2.49 | 14.9K | 651,460 | D | ↗ |
| 2025-08-07 | Taylor Andrew Lawrence | Officer | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 80,000 | 0.00 | — | 480,788 | D | ↗ |
| 2025-08-07 | Sherman Darren | Director / Officer | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 120,000 | 0.00 | — | 923,837 | D | ↗ |
| 2025-08-07 | Pacitti David | Director | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 15,000 | 0.00 | — | 44,968 | D | ↗ |
| 2025-08-07 | Mack John Prosper | Director | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 15,000 | 0.00 | — | 40,286 | D | ↗ |
| 2025-08-07 | Hochman David P | Director / Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 449,331 | I | ↗ |
| 2025-08-07 | Fain Eric S | Director | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 7,500 | 0.00 | — | 7,500 | D | ↗ |
| 2025-08-07 | Connealy Pamela Ann | Director | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 15,000 | 0.00 | — | 48,711 | D | ↗ |
| 2025-08-07 | Cleary Chris | Director | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 15,000 | 0.00 | — | 37,577 | D | ↗ |
| 2025-08-07 | Aryeh Jason | Director | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 15,000 | 0.00 | — | 107,482 | D | ↗ |
| 2025-08-07 | Aiello Joshua | Officer | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 15,000 | 0.00 | — | 19,329 | D | ↗ |
| 2025-08-04 | RTW INVESTMENTS, LP | 10% Owner | P-Purchase | A | Pre-Funded Warrants (Right to Buy) | 3,636,363 | 0.00 | 363.64 | 3,636,363 | I | ↗ |
| 2025-08-04 | Hochman David P | Director / Officer | P-Purchase | A | Common Stock, par value $0.0001 per share ("Common Stock") | 20,000 | 2.75 | 55.0K | 349,331 | I | ↗ |
| 2025-08-01 | PERCEPTIVE ADVISORS LLC | 10% Owner | P-Purchase | A | Common Stock | 700,000 | 2.75 | 1.93M | 5,292,556 | I | ↗ |
| 2025-06-26 | Fain Eric S | Director | S-Sale | D | Common Stock, par value $0.0001 per share ("Common Stock") | 2,683 | 3.05 | 8.2K | 50,949 | I | ↗ |
| 2025-06-24 | Pacitti David | Director | A-Award | A | Stock Option (Right to Buy) | 36,797 | 3.22 | 118.5K | 36,797 | D | ↗ |
| 2025-06-24 | Mack John Prosper | Director | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 12,422 | 0.00 | — | 25,286 | D | ↗ |
| 2025-06-24 | Fain Eric S | Director | A-Award | A | Stock Option (Right to Buy) | 36,797 | 3.22 | 118.5K | 36,797 | D | ↗ |
| 2025-06-24 | Connealy Pamela Ann | Director | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 12,422 | 0.00 | — | 33,711 | D | ↗ |
| 2025-06-24 | Cleary Chris | Director | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 12,422 | 0.00 | — | 22,577 | D | ↗ |
| 2025-06-24 | Aryeh Jason | Director | A-Award | A | Stock Option (Right to Buy) | 36,797 | 3.22 | 118.5K | 36,797 | D | ↗ |
| 2025-06-18 | Aiello Joshua | Officer | F-InKind | D | Common Stock, par value $0.0001 per share ("Common Stock") | 393 | 2.99 | 1.2K | 4,329 | D | ↗ |
| 2025-06-11 | Taylor Andrew Lawrence | Officer | F-InKind | D | Common Stock, par value $0.0001 per share ("Common Stock") | 28,172 | 3.14 | 88.5K | 400,788 | D | ↗ |
| 2025-06-11 | Hochman David P | Director / Officer | F-InKind | D | Common Stock, par value $0.0001 per share ("Common Stock") | 34,038 | 3.14 | 106.9K | 545,460 | D | ↗ |
| 2025-05-28 | Sherman Darren | Director / Officer | F-InKind | D | Common Stock, par value $0.0001 per share ("Common Stock") | 45,843 | 2.95 | 135.2K | 803,837 | D | ↗ |
| 2025-04-30 | RTW INVESTMENTS, LP | 10% Owner | P-Purchase | A | Common Stock | 49,900 | 2.99 | 149.2K | 8,306,063 | I | ↗ |
| 2025-04-29 | RTW INVESTMENTS, LP | 10% Owner | P-Purchase | A | Common Stock | 50,000 | 2.53 | 126.5K | 8,256,163 | I | ↗ |
| 2025-04-04 | Taylor Andrew Lawrence | Officer | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 84,000 | 0.00 | — | 428,960 | D | ↗ |
| 2025-04-04 | Sherman Darren | Director / Officer | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 115,708 | 0.00 | — | 849,680 | D | ↗ |
| 2025-04-04 | Hochman David P | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 147,500 | 2.76 | 407.1K | 147,500 | D | ↗ |
| 2025-04-04 | Aiello Joshua | Officer | A-Award | A | Stock Option (Right to Buy) | 48,000 | 2.76 | 132.5K | 48,000 | D | ↗ |
| 2025-03-26 | Aiello Joshua | Officer | F-InKind | D | Common Stock, par value $0.0001 per share | 278 | 4.38 | 1.2K | 4,722 | D | ↗ |
| 2025-03-07 | Hochman David P | Director / Officer | F-InKind | D | Common Stock, par value $0.0001 per share ("Common Stock") | 80,080 | 4.23 | 338.7K | 499,418 | D | ↗ |
| 2025-02-03 | Cleary Chris | Director | A-Award | A | Stock Option (Right to Buy) | 30,742 | 5.58 | 171.5K | 30,742 | D | ↗ |
| 2025-01-30 | Cleary Chris | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-12-27 | Aryeh Jason | Director | M-Exempt | D | Stock Option (Right to Buy) | 11,700 | 4.30 | 50.3K | 6,900 | D | ↗ |
| 2024-12-23 | Hochman David P | Director / Officer | P-Purchase | A | Common Stock, par value $0.0001 per share ("Common Stock") | 4,000 | 4.66 | 18.6K | 579,498 | D | ↗ |
| 2024-12-19 | Taylor Andrew Lawrence | Officer | P-Purchase | A | Common Stock, par value $0.0001 per share | 1,000 | 4.83 | 4.8K | 344,960 | D | ↗ |
| 2024-12-18 | Hochman David P | Director / Officer | P-Purchase | A | Common Stock, par value $0.0001 per share ("Common Stock") | 5,000 | 4.91 | 24.6K | 575,498 | D | ↗ |
| 2024-12-12 | Taylor Andrew Lawrence | Officer | F-InKind | D | Common Stock, par value $0.0001 per share | 34,403 | 5.03 | 173.0K | 343,960 | D | ↗ |
| 2024-12-05 | Sherman Darren | Director / Officer | F-InKind | D | Common Stock, par value $0.0001 per share ("Common Stock") | 31,815 | 5.57 | 177.2K | 733,972 | D | ↗ |
| 2024-09-25 | Hochman David P | Director / Officer | P-Purchase | A | Common Stock | 2,000 | 4.73 | 9.5K | 2,000 | I | ↗ |
| 2024-09-24 | Hochman David P | Director / Officer | P-Purchase | A | Common Stock, par value $0.0001 per share ("Common Stock") | 2,500 | 4.91 | 12.3K | 570,498 | D | ↗ |
| 2024-09-10 | Sherman Darren | Director / Officer | S-Sale | D | Common Stock | 6,904 | 5.31 | 36.7K | 765,787 | — | ↗ |
| 2024-09-10 | Fain Eric S | Director | S-Sale | D | Common Stock | 1,800 | 5.34 | 9.6K | 41,210 | — | ↗ |
| 2024-09-09 | Sherman Darren | Director / Officer | S-Sale | D | Common Stock, par value $0.0001 per share ("Common Stock") | 6,804 | 5.48 | 37.3K | 772,691 | — | ↗ |
| 2024-09-09 | Fain Eric S | Director | S-Sale | D | Common Stock | 1,800 | 5.43 | 9.8K | 43,010 | — | ↗ |
| 2024-09-06 | Sherman Darren | Director / Officer | S-Sale | D | Common Stock | 6,819 | 5.65 | 38.5K | 779,495 | — | ↗ |
| 2024-09-06 | Fain Eric S | Director | S-Sale | D | Common Stock, par value $0.0001 per share ("Common Stock") | 2,000 | 5.64 | 11.3K | 44,810 | — | ↗ |
| 2024-09-05 | Sherman Darren | Director / Officer | S-Sale | D | Common Stock | 6,961 | 5.85 | 40.7K | 786,314 | — | ↗ |
| 2024-09-04 | Sherman Darren | Director / Officer | S-Sale | D | Common Stock, par value $0.0001 per share ("Common Stock") | 6,837 | 6.10 | 41.7K | 793,275 | — | ↗ |
| 2024-08-14 | Hochman David P | Director / Officer | P-Purchase | A | Common Stock, par value $0.0001 per share ("Common Stock") | 2,500 | 5.84 | 14.6K | 567,998 | — | ↗ |
| 2024-08-07 | Mack John Prosper | Director | A-Award | A | Stock Option (Right to Buy) | 40,737 | 5.83 | 237.5K | 40,737 | — | ↗ |
| 2024-08-05 | HSAC 2 Holdings, LLC | 10% Owner | J-Other | D | Common Stock | 3,405,251 | 0.00 | — | 1,705,705 | — | ↗ |
| 2024-07-29 | Mack John Prosper | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-07-11 | PERCEPTIVE ADVISORS LLC | 10% Owner | — | I | Common Stock, $0.0001 par value per share | 0 | 0.00 | — | 4,592,556 | — | ↗ |
| 2024-06-25 | Hochman David P | Director / Officer | P-Purchase | A | Common Stock, par value $0.0001 per share ("Common Stock") | 1,000 | 6.95 | 7.0K | 333,502 | — | ↗ |
| 2024-06-20 | ROSE ERIC A MD | Director | A-Award | A | Stock Option (Right to Buy) | 17,068 | 7.44 | 127.0K | 17,068 | — | ↗ |
| 2024-06-20 | Pacitti David | Director | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 5,376 | 0.00 | — | 17,546 | — | ↗ |
| 2024-06-20 | Fain Eric S | Director | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 5,376 | 0.00 | — | 46,810 | — | ↗ |
| 2024-06-20 | Connealy Pamela Ann | Director | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 5,376 | 0.00 | — | 21,289 | — | ↗ |
| 2024-06-20 | Aryeh Jason | Director | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 5,376 | 0.00 | — | 68,360 | — | ↗ |
| 2024-05-30 | Little William Reed | Officer | P-Purchase | A | Common Stock, par value $0.0001 per share ("Common Stock") | 4,000 | 7.00 | 28.0K | 307,859 | — | ↗ |
| 2024-05-17 | Hochman David P | Director / Officer | P-Purchase | A | Common Stock | 3,000 | 5.15 | 15.5K | 332,502 | — | ↗ |
| 2024-05-16 | Hochman David P | Director / Officer | P-Purchase | A | Common Stock, par value $0.0001 per share ("Common Stock") | 2,000 | 4.75 | 9.5K | 329,502 | — | ↗ |
| 2024-05-08 | Taylor Andrew Lawrence | Officer | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 100,000 | 0.00 | — | 378,363 | — | ↗ |
| 2024-05-08 | Sherman Darren | Director / Officer | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 176,667 | 0.00 | — | 800,112 | — | ↗ |
| 2024-05-08 | Papandreou George | Officer | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 22,000 | 0.00 | — | 42,000 | — | ↗ |
| 2024-05-08 | Mika Yuval | Officer | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 69,333 | 0.00 | — | 158,905 | — | ↗ |
| 2024-05-08 | Little William Reed | Officer | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 53,333 | 0.00 | — | 303,859 | — | ↗ |
| 2024-05-08 | Hochman David P | Director / Officer | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 100,000 | 0.00 | — | 565,498 | — | ↗ |
| 2024-05-08 | Aiello Joshua | Officer | A-Award | A | Stock Option (Right to Buy) | 42,000 | 4.98 | 209.2K | 42,000 | — | ↗ |
| 2024-03-26 | Pacitti David | Director | A-Award | A | Common Stock, par value $0.0001 per share ("Common Stock") | 10,000 | 0.00 | — | 12,170 | — | ↗ |
| 2023-12-31 | Medtronic plc | 10% Owner | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-04-13 | RTW INVESTMENTS, LP | 10% Owner | J-Other | A | Common Stock | 502,133 | 15.00 | 7.53M | 5,620,645 | — | ↗ |
| 2023-01-26 | Yanchik Connealy Pamela | Director | — | D | Warrants (Right to Buy) | 15,000 | 11.50 | 172.5K | — | — | ↗ |
| 2023-01-26 | Smith Geoffrey Wade | Director | A-Award | A | Warrants (Right to Buy) | 519 | 10.00 | 5.2K | 519 | — | ↗ |
| 2023-01-26 | Sherman Darren | Officer | A-Award | A | Nonstatutory Stock Option (Right to Buy) | 508,397 | 10.00 | 5.08M | 508,397 | — | ↗ |
| 2023-01-26 | RTW INVESTMENTS, LP | Director | A-Award | A | Common Stock | 2,310,000 | 13.31 | 30.75M | 5,118,512 | — | ↗ |
| 2023-01-26 | ROSE ERIC A MD | Director | — | D | Warrants (Right to Buy) | 15,000 | 11.50 | 172.5K | — | — | ↗ |
| 2023-01-26 | Mika Yuval | Officer | — | D | Warrants (Right to Buy) | 50,000 | 11.50 | 575.0K | — | — | ↗ |
| 2023-01-26 | Kaswan Michael | Officer | — | D | Warrants (Right to Buy) | 75,000 | 11.50 | 862.5K | — | — | ↗ |
| 2023-01-26 | Hochman David P | Officer | A-Award | A | Incentive Stock Option (Right to Buy) | 6,743 | 4.06 | 27.4K | 6,743 | — | ↗ |
| 2023-01-26 | Fain Eric S | Director | — | D | Warrants (Right to Buy) | 15,000 | 11.50 | 172.5K | — | — | ↗ |
| 2023-01-26 | Aryeh Jason | Director | — | D | Warrants (Right to Buy) | 15,000 | 11.50 | 172.5K | — | — | ↗ |
| 2023-01-26 | Aiello Joshua | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-740.1K
Shares Outstanding
58.52M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | David P. Hochman Chief Executive Officer & Chairman | 595.0K | — | 996.0K | — | 309.4K | 12.1K | 1.91M | 52.08% | ↗ |
| 2 | 2024 | Darren R. Sherman President & Chief Operating Officer | 495.0K | 150.0K | 879.8K | — | 257.4K | 12.1K | 1.79M | 49.03% | ↗ |
| 3 | 2024 | Andrew L. Taylor Chief Financial Officer | 395.0K | — | 498.0K | — | 155.3K | 12.1K | 1.06M | 46.96% | ↗ |
| 4 | 2023 | David P. Hochman Chief Executive Officer & Chairman | 595.0K | — | 3.45M | 2.51M | 347.0K | 11.6K | 6.91M | 86.20% | ↗ |
| 5 | 2023 | Darren R. Sherman President & Chief Operating Officer | 495.0K | — | 4.00M | 1.66M | 292.0K | 11.6K | 6.46M | 87.64% | ↗ |
| 6 | 2023 | Andrew L. Taylor Chief Financial Officer | 227.0K | — | 2.07M | — | 99.4K | 6.9K | 2.40M | 86.11% | ↗ |
| 7 | 2022 | David P. Hochman Chief Executive Officer & Chairman | 395.0K | — | 63.0K | 2.30M | 395.0K | — | 3.16M | 74.97% | ↗ |
| 8 | 2022 | Darren R. Sherman President & Chief Operating Officer | 395.0K | — | — | 2.33M | 395.0K | — | 3.12M | 74.72% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| David Hochman | Founder, Chairman of the Board of Directors & Chief Executive Officer | 1M | male |
| Darren R. Sherman | Founder, President, Chief Operating Officer & Director | 1M | male |
| Andrew Lawrence Taylor | Chief Financial Officer | 766.7K | male |
| Hans-Peter Stoll | Senior Vice President & Medical Director | — | — |
| Juan Lorenzo | Senior Vice President of Product Development | — | male |
| Lisa Daniels | Vice President of Human Resources | — | female |
| William Reed Little | Executive Vice President of Corporate Development & Strategy | — | male |
| Yuval Hay Mika D.Sc | GM & Chief Technology Officer of Bioelectronic Therapies | — | — |
| Avraham Matityahu Fischer | Senior Vice President of Medical Affairs & Innovation | — | — |
| Bob Laughner | Senior Vice President of Regulatory & Quality | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for OBIO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
